Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months.
Chemotherapy-induced peripheral neuropathy affects nearly half of adult cancer patients; a new review finds that there is currently no way to predict who will be affected.
Some very recent research findings have added to the literature on the associations between migraine and depression, anxiety, and other disorders. Highlights here.